Moody Aldrich Partners »

Oruka Therapeutics shares owned by Moody Aldrich Partners

Quarter-by-quarter ownership of Oruka Therapeutics (ORKA) shares owned by Moody Aldrich Partners from 13F filings

Historical chart of Moody Aldrich Partners investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by Moody Aldrich Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by Moody Aldrich Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.8M 127k 30.31

More positions owned by Moody Aldrich Partners

Praxis Precision Medicines I Com New (PRAX)
Cadence Bank
Independent Bank (INDB)
Bridgebio Pharma (BBIO)
Columbia Banking System (COLB)
Wintrust Financial Corporation (WTFC)
Piper Jaffray Companies (PIPR)
Meta Financial (CASH)
Axsome Therapeutics (AXSM)
Portland Gen Elec Com New (POR)
Viatris (VTRS)
Karman Hldgs Common Stock (KRMN)
Protagonist Therapeutics (PTGX)
Element Solutions (ESI)
Modine Manufacturing (MOD)

View all positions for Moody Aldrich Partners

Top funds holding Oruka Therapeutics

FMR
VR Adviser
Fairmount Funds Management
BlackRock
Viking Global Investors
Vanguard Group
Deep Track Capital
Rtw Investments
Commodore Capital
Paradigm Biocapital Advisors
State Street Corporation
venBio Select Advisor
Perceptive Advisors
Polar Capital Holdings
Geode Capital Management

View all funds holding Oruka Therapeutics